A Leading Drug Delivery CDMO Dedicated To Your Lasting Legacy

Bringing a therapy from concept to commercial reality demands partners who can navigate complexity without slowing progress. This overview highlights a CDMO with deep expertise across inhalation, injectable, nasal, microneedle, and dermal drug delivery — offering integrated capabilities that streamline every phase of development. Programs gain the advantage of development‑by‑design methodology, device innovation, scale‑up support, and global regulatory guidance backed by decades of experience.

Teams can access formulation development, device design, prototyping, human factors studies, and full commercialization services, including aseptic fill finish, assembly, packaging, serialization, and lifecycle management. Advanced facilities — including state‑of‑the‑art sterile operations and sustainable propellant capability — provide the flexibility to support early feasibility work through large‑scale commercial supply.

With a legacy of industry firsts and global capacity that spans multiple manufacturing and R&D sites, this resource delivers the strategic value needed to accelerate timelines, mitigate risk, and bring high‑quality therapies to patients worldwide. Explore the full info sheet to see how these combined strengths can advance your program.